secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-03-11T23:59:59+00:00
Accession:  0001824293-25-000045
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio regains compliance with Nasdaq minimum bid price rule
-------------------------------------------------------------

- Received Nasdaq notice on March 10, 2025 confirming compliance with Listing Rule 5550(a)(2).
- Previously reported bid price deficiency in September 2024 filings.
- Company is now in full compliance and subject to no further action from Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000045/0001824293-25-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000045/val-20250310.htm
  HTML page:      https://secwatch.observer/filing/0001824293-25-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer